Articles
Home » Article
Tullow Oil is a FTSE 100 stock, with a market cap of £9bn. Not, then, a junior oil exploration company, or a fly-by-night with a couple of prospects. But what's interesting is that it offers a very different style of oil exposure from FTSE companions Bp and Royal Dutch Shell B - where the majors are actually beginning to exhaust their resources, Tullow is still increasing its resources with new discoveries.
Tullow's core area of operations is West Africa, where it is already producing in Gabon, Cote d'Ivoire, Mauretania, Congo and Equatorial Guinea, and has development programmes in… ...read more
Featured Author: Monkeynuts
I'm a business journalist and spend quite a lot of my time checking out interesting commodity stories - oil and gas, metals, agricultural plays, and most recently alternative energy investments. I know 'picks and shovels' made a lot of people money in the Internet boom years, but I prefer real physical picks and shovels, or drilling platforms and combine harvesters. But I do bear in mind that the price of my stocks is always going to be set by the supply and demand for the end product - so I am not a gold bug. Not at current prices, anyway!
13 articles
Latest Articles
54 mins ago by valueinvestor 0 comments
Tue 8:06pm by Sol Palha 0 comments
Tue 5:10pm by Stockopedia News 0 comments
Tue 3:25pm by Stockopedia News 0 comments
Tue 3:19pm by Edison Investment Research 0 comments
"Westminster has revealed the impressive growth in hits and enquiries driven by its revamped website, a core tool for its international agents. The development of the website has been a key driver in increasing the visibility and route to market of the group worldwide, and the benefits are beginning to feed through to increased quotation activity and ultimately future potential business. We feel that when this is combined with the recently announced framework contract for the MoJ and further wins for RMS, the group is demonstrating its potential in the UK and abroad."
Tue 2:20pm by Edison Investment Research 0 comments
"BrainJuicers preliminary results demonstrate that it continues to punch well above its weight in a weakened market research sector. The announcement of a second preferred supplier appointment by one of the worlds largest research buyers indicates the groups revolutionary techniques are building credibility where it matters. Strong cash flows support ambitions to become a major player through continuing to invest in new product and new markets. The rating is being eroded by the superior earnings growth and does not look stretched in an international context."
Tue 1:50pm by Stockopedia News 0 comments
Tue 1:46pm by Edison Investment Research 0 comments
"Lookers has delivered on its January trading statement, with a doubling of underlying pre-tax profits and a positive comment about the current year, which is running ahead of both internal budgets and the prior year. As we have indicated in earlier notes, there is a misconception in the City about the quality of earnings in certain leading motor dealership groups. Lookers has once again demonstrated the ability to grow in flat or modestly deteriorating markets. This factor is not recognised in the share price."
Tue 1:02pm by Stockopedia News 0 comments
Tue 11:53am by Hybridan 0 comments
Tue 11:23am by Edison Investment Research 0 comments
"Fiberwebs prospects remain healthy despite the uncertain economic environment. Restructuring initiatives supported robust 2009 results and increasing margin momentum in the second half helped push continuing operations into profit for the first time since Fiberwebs 2006 demerger. Recent refinancing leaves the group in a strong position to pursue its goal to grow both organically and via acquisitions. The valuation, both on a peer comparison basis and DCF analysis, is undemanding. "
Tue 9:25am by Edison Investment Research 0 comments
"Brewin Dolphin (BD) made a positive start to its financial year as income for Q110 increased 11.5%, and funds under management (FUM) rose 6% to £21.7bn. Investment Management revenue (the key to the group) was up 20.1% y-o-y. Since the December 2009 placing, the stock has underperformed and trades at a discount to its peers. BDs growth strategy and its healthy balance sheet should secure good earnings momentum unless there is a significant downturn in equity markets. The 2010 dividend gives a yield of 5.5%, 1.8x covered by normalised earnings."
Tue 9:04am by Edison Investment Research 0 comments
"Blue Star Capital has transformed itself into a homeland security focused investment company with four core investments. The new management team has vast and complementary experience across defence, security, police and industry, providing a detailed understanding of emerging opportunities. We believe that the focus on the growing homeland security sector provides significant upside potential for Blue Star and the prospects for current investee companies are promising. With the added interest generated by the Digital Barriers flotation, we feel that Blue Stars current valuation of a 20% premium to the published NAV is easily warranted."
Tue 8:06am by Fox Davies Capital 0 comments
Mon 5:08pm by Fat Prophets 0 comments
Mon 3:25pm by Edison Investment Research 0 comments
"In a tough market, K3 beat our forecast to grow revenues y-o-y. Recurring revenues increased to 42.5% (FY08: 41%) and total revenues from existing customers reached 79%. Recent contract wins will generate further higher margin service revenues in 2010 and the DigiMIS acquisition will open up cross-selling opportunities. In our view, the current valuation is undemanding. "
Mon 2:59pm by Edison Investment Research 0 comments
"2009 has been a strong year for Lloyds insurers, with Hardy no exception. But rates are softening as ample capital chases available business, even as investment earnings remain low. If underwriting discipline holds then returns will remain attractive and drive the book value growth that underpins share prices. Hardy benefits from the growth in premiums that will improve returns on capital raised in 2009. Dividend growth is set to continue at 10%. Hardy has a very strong underwriting track record but recent rapid growth through diversification has not been tested in a soft market and clearly represents a potential risk."
Mon 1:25pm by Stockopedia News 0 comments
Mon 12:37pm by Edison Investment Research 0 comments
"SuperGen is approaching a key event in terms of the outcome of an Eisai-sponsored Phase III study of Dacogen in elderly AML, which is due in the next few weeks. If successful, this should allow label expansion of the product in the US (and filing in the EU). Meanwhile, the FDA should complete its review of the five-day Dacogen dosing regime in the next few days (PDUFA date is 8 March). Management guidance suggests of an up to 10% growth in revenues for FY10 looks conservative, while R&D costs remain budgeted to maintain cash flow neutrality. "
Mon 11:41am by Stockopedia News 0 comments

